Cite
Powers SW, Coffey CS, Chamberlin LA, et al. Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Trial. JAMA Netw Open. 2021;4(7):e2114712doi: 10.1001/jamanetworkopen.2021.14712.
Powers, S. W., Coffey, C. S., Chamberlin, L. A., Ecklund, D. J., Klingner, E. A., Yankey, J. W., Peugh, J. L., Korbee, L. L., Simmons, K., Sullivan, S. M., Kabbouche, M. A., Kacperski, J., Porter, L. L., Reidy, B. L., & Hershey, A. D. (2021). Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Trial. JAMA network open, 4(7), e2114712. https://doi.org/10.1001/jamanetworkopen.2021.14712
Powers, Scott W, et al. "Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Trial." JAMA network open vol. 4,7 (2021): e2114712. doi: https://doi.org/10.1001/jamanetworkopen.2021.14712
Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Peugh JL, Korbee LL, Simmons K, Sullivan SM, Kabbouche MA, Kacperski J, Porter LL, Reidy BL, Hershey AD. Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Trial. JAMA Netw Open. 2021 Jul 01;4(7):e2114712. doi: 10.1001/jamanetworkopen.2021.14712. PMID: 34251445; PMCID: PMC8276084.
Copy
Download .nbib